Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 400 people enrolled
- Started
- 27 Nov 2023
- Ended
- 15 Aug 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- CareConnect
- AutoReach
- Biospecimen samples
- Record updated
- 29 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age 18 years and older
- Able to understand study procedures and to comply with them for the entire length of the study
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it
- English, Spanish, Cantonese, or Mandarin speaking
- Self-reported current use of tobacco, including e-cigarette on EHR
- Has a diagnosis of cancer
- Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months
Who cannot take part
- Contraindication to any study-related procedure or assessment
- No valid contact telephone number
- Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR)
Where in United States
- University of California San FranciscoSan Francisco, United States
About the trial
What the trial wants to find out
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
The 2 groups in the trial
- CareConnect (Intervention)Treatment being tested
Participants will receive automated 'CareConnect' calls/SMS text at enrollment. The call protocol includes up to 2 calls on 2 consecutive days if no response to first call. If there is no response to call, a follow up SMS 3-4 days later. Each CareConnect contact will include (1) assessment, (2) motivational enhancement tailored to participants' tobacco use status and importance of quitting; and (3) multiple referral options (UCSF Fontana Tobacco Treatment Center (FTTC)/tobacco treatment specialist, Quitline, or smoke-freeTXT from smokefree.gov), offered after the motivational enhancement message. CareConnect will notify UCSF tobacco treatment specialist of participants acceptance of any of referral options. Referral options will be documented by specialists on the participants electronic health record (EHR). Participants who have completed the CareConnect call will be contacted by research staff for a 3-month survey to be completed online, by telephone, or postal mail.
Treatment: CareConnect and Biospecimen samples
- AutoReach (Control)Other group
Participants will receive automated AutoReach calls/Short Message Service (SMS) text at enrollment provides one referral option (speaking with a tobacco treatment specialist) and an option for sending information on cessation resources. All participants who have completed the AutoReach call will be contacted by research staff for a 3-month survey to be completed online, by telephone or postal mail.
Treatment: AutoReach and Biospecimen samples
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach
- Record updated
- 29 October 2026